Beaton Management Company’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $2.25M | Sell |
10,366
-49
| -0.5% | -$10.9K | 1% | 34 |
|
|
2025
Q4 | $2.38M | Sell |
10,415
-13
| -0.1% | -$2.96K | 1.05% | 31 |
|
|
2025
Q3 | $2.42M | Buy |
10,428
+1
| +0% | +$204 | 1.1% | 31 |
|
|
2025
Q2 | $1.94M | Buy |
10,427
+77
| +0.7% | +$14.3K | 0.95% | 31 |
|
|
2025
Q1 | $2.17M | Sell |
10,350
-200
| -2% | -$38.9K | 1.13% | 28 |
|
|
2024
Q4 | $1.88M | Buy |
10,550
+116
| +1% | +$21.3K | 0.95% | 31 |
|
|
2024
Q3 | $2.06M | Sell |
10,434
-499
| -5% | -$93.1K | 1.04% | 30 |
|
|
2024
Q2 | $1.88M | Buy |
10,933
+48
| +0.4% | +$7.95K | 1.01% | 29 |
|
|
2024
Q1 | $1.98M | Buy |
10,885
+52
| +0.5% | +$8.96K | 1.08% | 28 |
|
|
2023
Q4 | $1.68M | Sell |
10,833
-65
| -0.6% | -$9.48K | 1.01% | 31 |
|
|
2023
Q3 | $1.63M | Buy |
10,898
+41
| +0.4% | +$6.02K | 1.06% | 30 |
|
|
2023
Q2 | $1.46M | Buy |
10,857
+238
| +2% | +$34.9K | 0.93% | 34 |
|
|
2023
Q1 | $1.69M | Sell |
10,619
-99
| -0.9% | -$15.1K | 1.14% | 29 |
|
|
2022
Q4 | $1.73M | Buy |
10,718
+2
| +0% | +$307 | 1.16% | 28 |
|
|
2022
Q3 | $1.44M | Sell |
10,716
-124
| -1% | -$17.8K | 1.09% | 30 |
|
|
2022
Q2 | $1.66M | Sell |
10,840
-164
| -1% | -$25.1K | 1.18% | 28 |
|
|
2022
Q1 | $1.78M | Buy |
11,004
+3
| +0% | +$436 | 1.1% | 27 |
|
|
2021
Q4 | $1.49M | Hold |
11,001
| – | – | 0.89% | 38 |
|
|
2021
Q3 | $1.19M | Buy |
11,001
+100
| +0.9% | +$11.4K | 0.79% | 39 |
|
|
2021
Q2 | $1.23M | Sell |
10,901
-200
| -2% | -$22.5K | 0.78% | 45 |
|
|
2021
Q1 | $1.2M | Buy |
11,101
+1,774
| +19% | +$190K | 0.83% | 41 |
|
|
2020
Q4 | $999K | Buy |
9,327
+100
| +1% | +$9.61K | 0.74% | 44 |
|
|
2020
Q3 | $808K | Sell |
9,227
-535
| -5% | -$50.4K | 0.67% | 52 |
|
|
2020
Q2 | $958K | Buy |
9,762
+1,777
| +22% | +$156K | 0.85% | 42 |
|
|
2020
Q1 | $608K | Buy |
7,985
+325
| +4% | +$27.7K | 0.61% | 58 |
|
|
2019
Q4 | $678K | Buy |
7,660
+300
| +4% | +$24.9K | 0.53% | 57 |
|
|
2019
Q3 | $557K | Buy |
7,360
+200
| +3% | +$13.7K | 0.45% | 66 |
|
|
2019
Q2 | $521K | Buy |
7,160
+250
| +4% | +$19.6K | 0.43% | 69 |
|
|
2019
Q1 | $557K | Hold |
6,910
| – | – | 0.48% | 64 |
|
|
2018
Q4 | $637K | Hold |
6,910
| – | – | 0.63% | 54 |
|
|
2018
Q3 | $654K | Hold |
6,910
| – | – | 0.54% | 55 |
|
|
2018
Q2 | $640K | Hold |
6,910
| – | – | 0.57% | 56 |
|
|
2018
Q1 | $654K | Hold |
6,910
| – | – | 0.6% | 54 |
|
|
2017
Q4 | $668K | Sell |
6,910
-366
| -5% | -$34.5K | 0.6% | 56 |
|
|
2017
Q3 | $647K | Hold |
7,276
| – | – | 0.61% | 55 |
|
|
2017
Q2 | $528K | Buy |
+7,276
| New | +$489K | 0.52% | 59 |
|
Other funds holding ABBV
VCM
VPM
Beaton Management Company's ABBV Position: Q1 2026 in Review
Beaton Management Company reduced its AbbVie (ABBV) stake by 0.47% in Q1 2026, selling an estimated $10.9K and leaving 10,366 shares worth $2.25M. The position accounts for 1% of the portfolio, ranked #34.
Beaton Management Company first reported a position in ABBV in Q2 2017 and has held it in 36 quarters since. The position peaked at $2.42M in Q3 2025. 4,077 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.
- Beaton Management Company held 10,366 shares of AbbVie worth $2.25M as of Q1 2026.
- Beaton Management Company sold 49 AbbVie shares in Q1 2026, an estimated $10.9K.
- AbbVie made up 1% of Beaton Management Company's portfolio in Q1 2026, its #34 holding.
- Beaton Management Company first reported a position in AbbVie in Q2 2017 and has held it in 36 quarters since.
- Beaton Management Company's AbbVie position peaked at $2.42M in Q3 2025.
- 4,077 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.
Based on Beaton Management Company's 13F filing for Q1 2026, filed 12 May 2026.